Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s Net Worth

$13.9 Million

Estimate Recalculated Nov 1, 2024 09:43AM EST

Who is Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Wellington Biomedical Innovation Master Investors (Cayman) II L.P. has an estimated net worth of $13.9 Million. This is based on reported shares across multiple companies, which include RayzeBio, Inc., and CARGO Therapeutics, Inc..

SEC CIK

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s CIK is 0001903360

Past Insider Trading and Trends

2023 was Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active year for acquiring shares with 2 total transactions. Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active month to acquire stocks was the month of August. 2023 was Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active year for disposing of shares, totalling 2 transactions. Wellington Biomedical Innovation Master Investors (Cayman) II L.P.'s most active month to dispose stocks was the month of August. 2023 saw Wellington Biomedical Innovation Master Investors (Cayman) II L.P. paying a total of $0.00 for 2,294,846 shares, this is the most they've acquired in one year. In 2023 Wellington Biomedical Innovation Master Investors (Cayman) II L.P. cashed out on 11,557,846 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RayzeBio, Inc.

Investor
Updated Sep 19, 2023
Form 4
Sep 19, 2023
1.56M
Options
Sep 19
Form 3
Sep 14, 2023
Showing 2 results

CARGO Therapeutics, Inc.

Investor
Updated Nov 16, 2023
Form 4
-92.63%
-9.26M
Nov 16, 2023
737.00K
Options
Nov 14
Form 3
Nov 13, 2023
Showing 2 results

MBX Biosciences, Inc.

Investor
Updated Sep 17, 2024
Form 4
-91.68%
-19.73M
Sep 17, 2024
1.79M
Options
Sep 16
Form 3
Sep 12, 2024
Showing 2 results

Upstream Bio, Inc.

Investor
Updated Oct 15, 2024
Form 4
4.90%
41.79K
Oct 15, 2024
894.73K
Options
Oct 15
Form 3
Oct 10, 2024
Showing 2 results